Rezolute RZLT
NASDAQ RZLT
$4.59 +0.05 (+1.21%)
As of: Sep 4, 2026 · 3:22 PM EDT

Rezolute (RZLT) Accumulated Expenses (2011 - 2026)

Rezolute (RZLT) posted Accumulated Expenses of $1.0 million for Q1 2026, down 32.51% sequentially from $1.5 million in Q4 2025, and down 0.96% YoY from $1.0 million in Q1 2025.

Analysis

Rezolute (RZLT) Accumulated Expenses (2011 - 2026) Analysis & Trends

Rezolute has reported Accumulated Expenses for 16 years, with the latest figure at $1.0 million in Q1 2026.

  • Quarterly Accumulated Expenses fell 0.96% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (down 0.96% YoY) and the FY2025 annual result came in at $2.3 million, up 25.22% from the prior year.
  • Accumulated Expenses declined to $1.0 million in Q1 2026 per RZLT's latest filing, from $1.5 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $4.0 million in Q4 2024 and troughed at $450000.0 in Q1 2022.
  • A 5-year average of $1.9 million and a median of $1.7 million in 2023 frame the typical range for Accumulated Expenses.
  • The sharpest annual moves came in 2022 and 2025: Accumulated Expenses surged 150.0% in 2022, then plunged 61.5% in 2025.
  • Over 5 years, Accumulated Expenses stood at $2.2 million in 2022, then grew by 11.15% to $2.5 million in 2023, then surged by 60.25% to $4.0 million in 2024, then slumped by 61.5% to $1.5 million in 2025, then slumped by 32.51% to $1.0 million in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $1.0 million, $1.5 million, and $3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 Rezolute 477.02 Mn 477.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.03 Mn
Dec 31, 2025 1.53 Mn
Sep 30, 2025 3.32 Mn
Jun 30, 2025 2.27 Mn
Mar 31, 2025 1.04 Mn
Dec 31, 2024 3.98 Mn
Sep 30, 2024 2.65 Mn
Jun 30, 2024 1.81 Mn
Mar 31, 2024 879,000.00
Dec 31, 2023 2.48 Mn
Sep 30, 2023 1.68 Mn
Jun 30, 2023 883,000.00
Dec 31, 2022 2.23 Mn
Mar 31, 2022 450,000.00
Dec 31, 2021 1.47 Mn
Jun 30, 2021 77,000.00
Mar 31, 2021 180,000.00
Dec 31, 2020 1.26 Mn
Sep 30, 2020 79,000.00
Jun 30, 2020 120,000.00